Viewing StudyNCT05137795



Ignite Creation Date: 2024-05-06 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 2:19 PM
Study NCT ID: NCT05137795
Status: WITHDRAWN
Last Update Posted: 2023-02-03
First Post: 2021-11-25

Brief Title: Inhaled ZYESAMI Aviptadil Acetate for Treatment of Severe COVID-19
Sponsor: APR Applied Pharma Research sa
Organization: APR Applied Pharma Research sa

Conditions & Keywords Data

Conditions:
Name
SARS-CoV 2
COVID
ARDS
ALI
Acute Lung InjuryAcute Respiratory Distress Syndrome ARDS
Dyspnea
Keywords:
Name View
Zyesami View
Corona Virus View
VIP View
Aviptadil View
Vasoactive Intestinal Polypeptide View